Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

INSM

Insmed Incorporated · Healthcare · Biotechnology

124.39 +0.4% mkt cap $26.96B quote delayed (FMP) · as of Aug 26 22:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
18Tracked holders
+1Δ holders
70.35MShares held
$7.08BReported value
+2New positions
−1Exits
Rising Conviction score 54/100 3 quarters of rising tracked shares ●●●○○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +5.9% · share flow +3.7% · net new positions +5.6%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 158 -6 147.56M $15.74B +6 −11
Q1 2026 166 +6 152.11M $24.63B +9 −4
Q4 2025 159 -1 156.45M $27.23B +1 −1
Q3 2025 21 +1 121.03M $17.43B +1 −1
Q2 2025 18 +1 70.35M $7.08B +2 −1
Q1 2025 14 -1 33.99M $2.59B −1
Q4 2024 15 0 31.46M $2.17B +1 −1
Q3 2024 14 -1 23.46M $1.71B −1
Q2 2024 15 25.91M $1.74B
Holder count
Who holds it · Q2 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 The Vanguard Group (passive) 17.64M $1.78B 0.0% n/c 1 SEC ↗
2 The Vanguard Group (passive) 17.64M $1.78B 0.0% n/c 1 SEC ↗
3 The Vanguard Group (passive) 17.64M $1.78B 0.0% n/c 1 SEC ↗
4 The Vanguard Group (passive) 17.64M $1.78B 0.0% n/c 1 SEC ↗
5 The Vanguard Group (passive) 17.64M $1.78B 0.0% n/c 1 SEC ↗
6 T. Rowe Price 11.23M -13.1% $1.13B 0.1% ▼ Trim 5 SEC ↗
7 T. Rowe Price 11.23M -13.1% $1.13B 0.1% ▼ Trim 5 SEC ↗
8 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
9 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
10 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
11 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
12 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
13 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
14 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
15 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
16 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
17 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
18 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
19 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
20 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
21 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
22 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
23 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
24 BlackRock (passive) 11.14M $1.12B 0.0% n/c 1 SEC ↗
25 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
26 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
27 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
28 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
29 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
30 Fidelity (FMR) 5.09M $512.59M 0.0% n/c 1 SEC ↗
31 State Street Global Advisors (passive) 4.28M -25.6% $430.53M 0.0% ▼ Trim 3 SEC ↗
32 D. E. Shaw & Co. 3.42M +365.7% $344.45M 0.4% ▲ Add 5 SEC ↗
33 D. E. Shaw & Co. 3.42M +365.7% $344.45M 0.4% ▲ Add 5 SEC ↗
34 Geode Capital Management (passive) 3.34M -22.1% $336.26M 0.0% ▼ Trim 5 SEC ↗
35 Geode Capital Management (passive) 3.34M -22.1% $336.26M 0.0% ▼ Trim 5 SEC ↗
36 Adage Capital Partners 2.86M -17.0% $287.78M 0.5% ▼ Trim 5 SEC ↗
37 Duquesne Family Office 2.25M +64.6% $226.79M 5.8% ▲ Add 5 SEC ↗
38 Millennium Management 2.12M +212.4% $213.53M 0.2% ▲ Add 5 SEC ↗
39 Norges Bank (passive) 1.93M +11.0% $194.73M 0.0% ▲ Add 5 SEC ↗
40 Citadel Advisors 1.53M +309.1% $154.31M 0.1% ▲ Add 5 SEC ↗
41 Citadel Advisors 1.53M +309.1% $154.31M 0.1% ▲ Add 5 SEC ↗
42 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
43 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
44 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
45 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
46 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
47 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
48 Wellington Management 1.16M -5.2% $116.71M 0.0% ▼ Trim 5 SEC ↗
49 Marshall Wace 1.11M +59.9% $112.05M 0.1% ▲ Add 5 SEC ↗
50 Marshall Wace 1.11M +59.9% $112.05M 0.1% ▲ Add 5 SEC ↗
51 Marshall Wace 1.11M +59.9% $112.05M 0.1% ▲ Add 5 SEC ↗
52 Point72 Asset Management 490.67K New $49.38M 0.1% New 1 SEC ↗
53 Two Sigma Investments 376.51K -7.5% $37.89M 0.1% ▼ Trim 5 SEC ↗
54 Renaissance Technologies 308.69K New $31.07M 0.0% New 1 SEC ↗
55 AQR Capital Management 49.72K -3.0% $5.00M 0.0% ▼ Trim 5 SEC ↗
56 AQR Capital Management 49.72K -3.0% $5.00M 0.0% ▼ Trim 5 SEC ↗
57 AQR Capital Management 49.72K -3.0% $5.00M 0.0% ▼ Trim 5 SEC ↗
58 AQR Capital Management 49.72K -3.0% $5.00M 0.0% ▼ Trim 5 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Point72 Asset Management $49.38M 0.1%
Renaissance Technologies $31.07M 0.0%

Exited

Soros Fund Management $23.44M was 0.6%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 664 holders, 192.22M shares, $30.07B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

No open-market insider purchases in our coverage window.

Open-market sales (S)

Aug 17 SHAROKY MELVIN MD

Director · 5.00K sh · $637,650

Aug 10 Adsett Roger

Officer · 239.85K sh · $31.96M

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Aug 14 SC 13G/A — Darwin Global Management, Ltd.

View original SEC filing ↗

Aug 06 SC 13G/A — FMR LLC

View original SEC filing ↗

Jul 22 SC 13G/A — JPMORGAN CHASE & CO

View original SEC filing ↗

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q2 2025 · Methodology · Get this via the API